Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension Without Change of a Previously Approved Collection; Title-Application for Individual Manufacturing Quota for a Basic Class of Controlled Substance and for Ephedrine, Pseudoephedrine, and Phenylpropanolamine (DEA Form 189)
The Drug Enforcement Administration (DEA), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (O...
Drug Enforcement Administration, Department of Justice.
ACTION:
60-Day notice.
SUMMARY:
The Drug Enforcement Administration (DEA), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
DATES:
Comments are encouraged and will be accepted for 60 days until November 23, 2026.
FOR FURTHER INFORMATION CONTACT:
If you have additional comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Heather Achbach, Regulatory Drafting and Policy Support Section, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 776-3882; Email:
Heather.E.Achbach@dea.gov
or
DEA.PRA@dea.gov.
SUPPLEMENTARY INFORMATION:
Written comments and suggestions from the public and affected agencies concerning
( printed page 60418)
the proposed collection of information are encouraged. Your comments should address one or more of the following four points:
—Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the Bureau of Justice Statistics, including whether the information will have practical utility;
—Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;
—Evaluate whether and if so how the quality, utility, and clarity of the information to be collected can be enhanced; and
—Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology,
e.g.,
permitting electronic submission of responses.
Abstract:
Pursuant to 21 U.S.C. 826(c) and 21 CFR 1303.22 and 1315.22, any person who is registered to manufacture any basic class of controlled substances listed in Schedule I or II, or the List I chemicals ephedrine, pseudoephedrine, or phenylpropanolamine, and who desires to manufacture a quantity of such class or such List I chemical, must apply on DEA Form 189 for a manufacturing quota for such quantity of such class or List I chemical.
Overview of This Information Collection
1.
Type of Information Collection:
Extension of a currently approved collection.
2.
Title of the Form/Collection:
Application for Individual Manufacturing Quota for a Basic Class of Controlled Substance and for Ephedrine, Pseudoephedrine, and Phenylpropanolamine.
3.
The agency form number, if any, and the applicable component of the Department sponsoring the collection:
The form number is DEA Form 189. The applicable component within the Department of Justice is the Drug Enforcement Administration, Diversion Control Division.
4.
Affected public who will be asked or required to respond, as well as the obligation to respond:
The affected Public would be Business or other for-profit. The obligation to respond is mandatory to receive Individual Manufacturing Quota.
5.
An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond:
The DEA estimates that 803 registrants participate in this information collection. The time per response is 30 minutes.
6.
An estimate of the total annual burden (in hours) associated with the collection:
DEA estimates that this collection takes 402 annual burden hours.
7.
An estimate of the total annual cost burden associated with the collection, if applicable:
$0.
Total Burden Hours
Activity
Number of
respondents
Frequency
Total annual
responses
Time per
response
(hours)
Total annual
burden
(hours)
DEA Form 189
42
19.11904762
803
0.5
402
Unduplicated Totals
42
19.11904762
803
0.5
402
If additional information is required contact:
Darwin Arceo, Department Clearance Officer, United States Department of Justice, Justice Management Division, Enterprise Portfolio Management, Two Constitution Square, 145 N Street NE, 4W-218, Washington, DC.
Dated: September 21, 2026.
Darwin Arceo,
Department Clearance Officer for PRA, U.S. Department of Justice.
Use this for formal legal and research references to the published document.
91 FR 60417
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension Without Change of a Previously Approved Collection; Title-Application for Individual Manufacturing Quota for a Basic Class of Controlled Substance and for Ephedrine, Pseudoephedrine, and Phenylpropanolamine (DEA Form 189),” thefederalregister.org (September 23, 2026), https://thefederalregister.org/documents/2026-19435/agency-information-collection-activities-proposed-ecollection-ecomments-requested-extension-without-change-of-a-previous.
21 U.S.C. 826(c)
21 CFR 1303.22